K.G. Zhestkov, R.T. Yaduta
Russian Medical Academy of Postgraduate Education of Russian Ministry of Healthcare, Moscow
Yaduta R.T. ― postgraduate student of the Department of Thoracic Surgery of the Russian Medical Academy of Postgraduate Education of Russian Ministry of Healthcare
2/1 Barrikadnaya St., Moscow, Russian Federation, 125993, tel. +7-925-024-06-54, e-mail: firstname.lastname@example.org
Abstract. According to world literature, the proportion of metastatic pleurisy remains very high. The presence of pleurisy is a key factor in lowering the quality of life of patients, and the continuation of the combined anti-tumor therapy is possible after the evacuation of fluid. The trend of recent years becomes active surgical tactics in metastatic pleurisy. On the basis of studies in cadaver material offered advanced equipment thoracoscopic pleurectomy and decortication of the lung, which has been tested in clinical practice, as a variant of cytoreductive surgery and method of obliteration of the pleural cavity in patients with metastatic pleurisy.
Key words: metastatic pleural effusion, pleural cavity obliteration, VATS P/D.
1. Bondarev A.A., Myasnikov A.D., Rabotskiy I.A. Criteria for assessing the surgical approaches in endosurgery. Endoskopicheskaya khirurgiya, 2003, no. 4, pp. 47-53 (in Russ.).
2. Shulutko A.M., Ovchinnikov A.A., Yasnogorodskiy O.O., Motus I.Ya. Endoskopicheskaya torakal'naya khirurgiya: rukovodstvo dlya vrachey [Endoscopic Thoracic Surgery: A Guide for Physicians]. Moscow: OAO “Izdatel'stvo Meditsina”, 2006, 391 p.
3. Yaduta R.T., Zhestkov K.G., Barskiy B.G. Treatment of metastatic pleurisy: criteria for selection of surgical approach. Vrach Skoroy Pomoshchi, 2015, no. 1, pp. 23-26 (in Russ.).
4. Bell D. et al. A retrospective review of the palliative surgical management of malignant, pleural effusions. BMJ suppotlive & palliative care, 2013, p. 21.
5. Larson T., Melnikova N., Davis S.I. et al. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002. Int. J. Occup. Environ. Health, 2007, vol. 13, pp. 398-403.
6. Loïc Lang-Lazdunski et al. Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma. J. Thorac. Oncol, 2012, vol. 7, no. 4, pp. 737-743.
7. Meuris K. Subtotal pleurectomy by video-assisted thoracic surgery for metastatic pleuritis. Multimed Man Cardiothorac. Surg, 2012, vol. 1, pp. 1-5.
8. Michael I. Lewis et al. Medical management of the thoracic surgery patient, 2010. P. 540.
9. Mishra E., Davies H.E., Lee Y.C.G. Malignant pleural disease in primary lung cancer. In: S.G. Spiro, S.M. Janes, R.M. Huber (eds.). Thoracic Malignancies ― Sheffield, UK. European Respiratory Society Journals Ltd, 2009. Pp. 318-335.
10. Roberts M.E. et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline. Thorax, 2010, vol. 65, sup. 2, pp. 32-40.
11. Rodriges-Panadero F. et al. Thorcoscopy: general overview and place in the diagnosis and managment of pleural effusion. Eur. Resspir. J, 2006, vol. 28, pp. 409-426.
12. Sahn S.A. Malignant pleural effusions. In: Bouros D., (ed). Pleural Disease. 2nd edn. New York: Informa Healthcare USA, Inc., 2010. Pp. 402-26.